Effects of weekly bevacizumab and paclitaxel/carboplatin with or without sorafenib on heavily pretreated patients with recurrent or persistent cervical cancer.
Y. Kikuchi
No relevant relationships to disclose
M. Takano
No relevant relationships to disclose
T. Goto
No relevant relationships to disclose
H. Kouta
No relevant relationships to disclose
R. Kikuchi
No relevant relationships to disclose
K. Kudoh
No relevant relationships to disclose
T. Kita
No relevant relationships to disclose
K. Furuya
No relevant relationships to disclose
K. Umayahara
No relevant relationships to disclose
K. Takizawa
No relevant relationships to disclose